| Breakdown | TTM | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.14B | 62.51B | 58.45B | 57.56B | 62.34B | 31.61B |
| Gross Profit | 4.43B | 4.37B | 3.54B | 3.58B | 3.56B | 1.77B |
| EBITDA | 1.91B | 1.83B | 1.60B | 1.51B | 1.49B | 731.90M |
| Net Income | 987.04M | 827.66M | 689.09M | 626.91M | 651.31M | 395.07M |
Balance Sheet | ||||||
| Total Assets | 35.08B | 34.25B | 30.27B | 29.41B | 29.73B | 27.67B |
| Cash, Cash Equivalents and Short-Term Investments | 1.56B | 2.44B | 1.06B | 1.03B | 522.60M | 993.97M |
| Total Debt | 1.13B | 4.61B | 3.91B | 4.08B | 4.10B | 4.14B |
| Total Liabilities | 26.30B | 25.80B | 22.24B | 21.23B | 21.71B | 19.76B |
| Stockholders Equity | 8.78B | 8.45B | 8.04B | 8.18B | 8.03B | 7.91B |
Cash Flow | ||||||
| Free Cash Flow | 1.25B | 1.39B | 1.04B | 1.26B | -166.65M | 754.89M |
| Operating Cash Flow | 1.38B | 1.53B | 1.22B | 1.41B | -49.60M | 809.79M |
| Investing Cash Flow | -188.23M | -221.17M | -193.84M | -156.41M | -115.51M | -952.35M |
| Financing Cash Flow | -313.88M | -32.87M | -953.10M | -785.88M | -275.59M | -392.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $16.61B | 9.59 | 11.60% | 1.15% | 6.95% | 19.19% | |
74 Outperform | $1.62B | 17.40 | 9.37% | 1.02% | 3.19% | -4.91% | |
71 Outperform | $6.02B | 16.25 | 4.22% | 2.77% | -2.30% | -29.75% | |
67 Neutral | $841.17M | 12.95 | 8.14% | ― | -4.88% | 2.57% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | $8.93B | 9.99 | 9.05% | ― | 3.16% | 1.09% | |
59 Neutral | $2.22B | 16.31 | 9.79% | ― | -6.69% | -51.74% |